{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:47:27Z","timestamp":1765486047623},"reference-count":36,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.3892\/ol.2016.4965","type":"journal-article","created":{"date-parts":[[2016,8,5]],"date-time":"2016-08-05T12:14:03Z","timestamp":1470399243000},"page":"2363-2370","source":"Crossref","is-referenced-by-count":5,"title":["Combined use of free light chain and heavy\/light chain ratios allow diagnosis and monitoring of patients with monoclonal gammopathies: Experience of a single institute, with three exemplar case reports"],"prefix":"10.3892","volume":"12","author":[{"given":"Alfredo","family":"Gagliardi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosanna","family":"Cuccurullo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Lucania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola Della","family":"Cioppa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriella","family":"Misso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Caraglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catello","family":"Tommasino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Mastrullo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2016,8,5]]},"reference":[{"key":"key20180108110820_b1-ol-0-0-4965","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/sj.thj.6200312","article-title":"Scientific Advisors of the International Myeloma Foundation: Myeloma management guidelines: A consensus report from the Scientific Advisors of the International Myeloma Foundation","volume":"4","author":"Durie","year":"2003","journal-title":"Hematol J"},{"key":"key20180108110820_b2-ol-0-0-4965","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/leu.2010.60","article-title":"International Myeloma Working Group: Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management","volume":"24","author":"Kyle","year":"2010","journal-title":"Leukemia"},{"key":"key20180108110820_b3-ol-0-0-4965","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.2169\/internalmedicine.51.7860","article-title":"Attainment of a stringent complete response in multiple myeloma with thalidomide monotherapy","volume":"51","author":"Aritaka","year":"2012","journal-title":"Intern Med"},{"key":"key20180108110820_b4-ol-0-0-4965","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1038\/leu.2015.118","article-title":"Utility of serum free light chain measurements in multiple myeloma patients not achieving complete response to therapy","volume":"29","author":"Moustafa","year":"2015","journal-title":"Leukemia"},{"key":"key20180108110820_b5-ol-0-0-4965","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1373\/clinchem.2009.126664","article-title":"Screening panels for detection of monoclonal gammopathies","volume":"55","author":"Katzmann","year":"2009","journal-title":"Clin Chem"},{"key":"key20180108110820_b6-ol-0-0-4965","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1373\/clinchem.2009.124461","article-title":"Quantitation of serum monoclonal proteins: Relationship between agarose gel electrophoresis and immunonephelometry","volume":"55","author":"Murray","year":"2009","journal-title":"Clin Chem"},{"key":"key20180108110820_b7-ol-0-0-4965","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1093\/clinchem\/47.4.673","article-title":"Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine","volume":"47","author":"Bradwell","year":"2001","journal-title":"Clin Chem"},{"key":"key20180108110820_b8-ol-0-0-4965","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/leu.2008.307","article-title":"International Myeloma Working Group: International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders","volume":"23","author":"Dispenzieri","year":"2009","journal-title":"Leukemia"},{"key":"key20180108110820_b9-ol-0-0-4965","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.1182\/blood-2010-10-299487","article-title":"International Myeloma Workshop Consensus Panel 1: Consensus recommendations for the uniform reporting of clinical trials: Report of the International Myeloma Workshop Consensus Panel I","volume":"117","author":"Rajkumar","year":"2011","journal-title":"Blood"},{"key":"key20180108110820_b10-ol-0-0-4965","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"Rajkumar","year":"2014","journal-title":"Lancet Oncol"},{"key":"key20180108110820_b11-ol-0-0-4965","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1373\/clinchem.2009.123828","article-title":"Assessment of monoclonal gammopathies by nephelometric measurement of individual immunoglobulin kappa\/lambda ratios","volume":"55","author":"Bradwell","year":"2009","journal-title":"Clin Chem"},{"key":"key20180108110820_b12-ol-0-0-4965","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1365-2141.2004.04970.x","article-title":"British Committee for Standards in Haematology, British Society for Haematology: Guidelines on the diagnosis and management of AL amyloidosis","volume":"125","year":"2004","journal-title":"Br J Haematol"},{"key":"key20180108110820_b13-ol-0-0-4965","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.1365-2141.2009.07807.x","article-title":"Haemato-oncology Task Force of the British Committee for Standards in Haematology, UK Myeloma Forum and Nordic Myeloma Study Group: UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): Guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS)","volume":"147","author":"Bird","year":"2009","journal-title":"Br J Haematol"},{"key":"key20180108110820_b14-ol-0-0-4965","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1182\/blood-2010-10-299529","article-title":"International Myeloma Workshop Consensus Panel 3: Consensus recommendations for standard investigative workup: Report of the International Myeloma Workshop Consensus Panel 3","volume":"117","author":"Dimopoulos","year":"2011","journal-title":"Blood"},{"key":"key20180108110820_b15-ol-0-0-4965","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2141.2004.05045.x","article-title":"Serum free light chains for monitoring multiple myeloma","volume":"126","author":"Mead","year":"2004","journal-title":"Br J Haematol"},{"key":"key20180108110820_b16-ol-0-0-4965","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1309\/LMPHODC7R1L0MEWW","article-title":"Serum free light chain analysis for diagnosis, monitoring, and prognosis of monoclonal gammopathies","volume":"40","author":"Siegel","year":"2009","journal-title":"Lab Med"},{"key":"key20180108110820_b17-ol-0-0-4965","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1365-2141.2005.05867.x","article-title":"UK Myeloma Forum; Nordic Myeloma Study Group; British Committee for Standards in Haematology: Guidelines on the diagnosis and management of multiple myeloma 2005","volume":"132","author":"Smith","year":"2006","journal-title":"Br J Haematol"},{"key":"key20180108110820_b18-ol-0-0-4965","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1373\/clinchem.2011.163766","article-title":"A 71-year-old woman with multiple myeloma status after stem cell transplantation","volume":"57","author":"Donato","year":"2011","journal-title":"Clin Chem"},{"key":"key20180108110820_b19-ol-0-0-4965","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1258\/acb.2009.009038","article-title":"Serum free light chain assay reduces the need for serum and urine immunofixation electrophoresis in the evaluation of monoclonal gammopathy","volume":"46","author":"Fulton","year":"2009","journal-title":"Ann Clin Biochem"},{"key":"key20180108110820_b20-ol-0-0-4965","first-page":"154","article-title":"Prevalence of the monoclonal gammopathy of undetermined significance (MGUS) in out-patients >50 years old: An indication to carry out electrophoresis of serum protein?","volume":"38","author":"Vernocchi","year":"2014","journal-title":"Biochim Clin"},{"key":"key20180108110820_b21-ol-0-0-4965","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.3109\/10428194.2015.1028056","article-title":"Utility of the immunoglobulin free light chain assay for plasma cell disorders 2015","volume":"56","author":"Gertz","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"key20180108110820_b22-ol-0-0-4965","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(03)12457-9","article-title":"Serum test for assessment of patients with Bence Jones myeloma","volume":"361","author":"Bradwell","year":"2003","journal-title":"Lancet"},{"key":"key20180108110820_b23-ol-0-0-4965","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1182\/blood.V97.9.2900","article-title":"Serum free light-chain measurements for identifying and monitoring patients with nonsecretory multiple myeloma","volume":"97","author":"Drayson","year":"2001","journal-title":"Blood"},{"key":"key20180108110820_b24-ol-0-0-4965","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1182\/blood-2013-12-542662","article-title":"Serum free immunoglobulin light chain evaluation as a marker of impact from intraclonal heterogeneity on myeloma outcome","volume":"123","author":"Brioli","year":"2014","journal-title":"Blood"},{"key":"key20180108110820_b25-ol-0-0-4965","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/leu.2012.201","article-title":"A window into immunoglobulin quantitation and plasma cell disease: Antigen epitopes defined by the junction of immunoglobulin heavy and light chains","volume":"27","author":"Katzmann","year":"2013","journal-title":"Leukemia"},{"key":"key20180108110820_b26-ol-0-0-4965","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/leu.2012.197","article-title":"Immunoglobulin heavy\/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patients","volume":"27","author":"Ludwig","year":"2013","journal-title":"Leukemia"},{"key":"key20180108110820_b27-ol-0-0-4965","first-page":"157","article-title":"Evaluation of the new Hevylite\u2122 IgA assay for the diagnosis and follow-up of monoclonal gammopathies","volume":"71","author":"Lakomy","year":"2013","journal-title":"Ann Biol Clin (Paris)"},{"key":"key20180108110820_b28-ol-0-0-4965","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1373\/clinchem.2009.132753","article-title":"Heavy\/light-chain analysis of monoclonal gammopathies","volume":"55","author":"Keren","year":"2009","journal-title":"Clin Chem"},{"key":"key20180108110820_b29-ol-0-0-4965","first-page":"383","article-title":"Simultaneous evaluation of serum Hevylite and Freelite assays for relapse prediction in multiple myeloma","volume":"37","author":"Astolfi","year":"2013","journal-title":"Biochim Clin"},{"key":"key20180108110820_b30-ol-0-0-4965","doi-asserted-by":"crossref","first-page":"e493","DOI":"10.14694\/EdBook_AM.2015.35.e493","article-title":"Multiple myeloma: Is it time for biomarker-driven therapy?","volume":"35","author":"Bhutani","year":"2015","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"key20180108110820_b31-ol-0-0-4965","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1158\/1078-0432.CCR-13-2159","article-title":"Biologic frontiers in multiple myeloma: From biomarker identification to clinical practice","volume":"20","author":"Landgren","year":"2014","journal-title":"Clin Cancer Res"},{"key":"key20180108110820_b32-ol-0-0-4965","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1177\/0004563214564225","article-title":"Comparison of Hevylite\u2122 IgA and IgG assay with conventional techniques for the diagnosis and follow-up of plasma cell dyscrasia","volume":"52","author":"Paolini","year":"2015","journal-title":"Ann Clin Biochem"},{"key":"key20180108110820_b33-ol-0-0-4965","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1373\/clinchem.2014.231985","article-title":"Monitoring IgA multiple myeloma: Immunoglobulin heavy\/light chain assays","volume":"61","author":"Katzmann","year":"2015","journal-title":"Clin Chem"},{"key":"key20180108110820_b34-ol-0-0-4965","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/leu.2012.159","article-title":"Prognostic utility of intact immunoglobulin Ig'\u03ba\/Ig'\u03bb ratios in multiple myeloma patients","volume":"27","author":"Bradwell","year":"2013","journal-title":"Leukemia"},{"key":"key20180108110820_b35-ol-0-0-4965","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2162-3619-1-9","article-title":"Ratio of involved\/uninvolved immunoglobulin quantification by Hevylite\u2122 assay: Clinical and prognostic impact in multiple myeloma","volume":"1","author":"Koulieris","year":"2012","journal-title":"Exp Hematol Oncol"},{"key":"key20180108110820_b36-ol-0-0-4965","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1182\/blood-2014-09-568899","article-title":"Smoldering multiple myeloma","volume":"125","author":"Rajkumar","year":"2015","journal-title":"Blood"}],"container-title":["Oncology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ol.2016.4965\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T05:39:12Z","timestamp":1656999552000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ol.2016.4965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,5]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2016,8,5]]},"published-print":{"date-parts":[[2016,10]]}},"alternative-id":["10.3892\/ol.2016.4965"],"URL":"https:\/\/doi.org\/10.3892\/ol.2016.4965","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,5]]}}}